Two Sigma Advisers »

Intra Cellular Therapies shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-03-31 $5.1M 39k 131.92
2024-12-31 $12M 143k 83.52
2021-12-31 $600k 12k 52.32
2020-03-31 $192k 13k 15.40
2019-12-31 $788k 23k 34.31
2019-09-30 $1.0M 139k 7.47
2019-06-30 $2.1M 165k 12.98
2019-03-31 $1.5M 126k 12.18
2018-12-31 $322k 28k 11.39

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Meta Platforms Cl A (META)
Bank of America Corporation (BAC)
Mastercard Incorporated Cl A (MA)
Costco Wholesale Corporation (COST)
Lockheed Martin Corporation (LMT)
Intuitive Surgical Com New (ISRG)
Adobe Systems Incorporated (ADBE)
Charles Schwab Corporation (SCHW)

View all positions for Two Sigma Advisers

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies